ストックスクリーナーアプリを入手
2.53
0.98%
-0.01
前日終値:
$2.54
開ける：
$2.53
24時間の取引高:
57,108
Relative Volume:
0.01
時価総額：
$45.07M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-4.01%
1か月 パフォーマンス:
+122.57%
6か月 パフォーマンス:
-25.37%
1年 パフォーマンス:
-33.47%
1日の値動き範囲:
$2.50
$2.54
1週間の範囲:
$2.50
$2.68
52週間の値動き範囲:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
MURA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.53 | 45.07M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.51 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
583.48 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
646.35 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
252.57 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-04 | 開始されました | Morgan Stanley | Overweight |
Mural Oncology Plc (MURA) 最新ニュース
Layoff Tracker: Pliant Cuts 45% of Staff To Extend Cash Runway - BioSpace
Geode Capital Management LLC Sells 9,027 Shares of Mural Oncology plc (NASDAQ:MURA) - Defense World
Goldman Sachs adjusts positions in Mural Oncology shares By Investing.com - Investing.com Nigeria
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology - Investing.com Australia
Form 8.3Mural Oncology plc - Business Wire
Goldman Sachs adjusts positions in Mural Oncology shares - Investing.com Australia
Goldman Sachs discloses stake in Mural Oncology By Investing.com - Investing.com India
Goldman Sachs discloses stake in Mural Oncology - Investing.com
Renaissance Technologies LLC Boosts Stock Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World
Ovarian Cancer Market: Epidemiology, Therapies, Companies, - openPR.com
BlackRock discloses stake in Mural Oncology plc - Investing.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com India
Goldman Sachs adjusts stake in Mural Oncology - Investing.com
Mural Oncology plc Opening Position Disclosure Under Irish Takeover Rules - Nasdaq
FORM 8.1(a) & (b)Mural Oncology plc - The Manila Times
Mural Oncology Takeover Speculation Heats Up as CEO Stakes Revealed: 900K+ Total Shares - Stock Titan
Tang Capital reports stake in Mural Oncology - Investing.com
March sees multiple phase III successes, boosting Corcept and Mineralys - BioWorld MedTech
LMR Partners reports 2.997% stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology amid takeover rules By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology - Investing.com Australia
BlackRock discloses stake in Mural Oncology amid takeover rules - Investing.com Australia
LMR Partners reports 2.997% stake in Mural Oncology - Investing.com Australia
Tang Capital discloses stake in Mural Oncology By Investing.com - Investing.com India
Tang Capital discloses stake in Mural Oncology - Investing.com
Solas Capital discloses dealings in Mural Oncology shares By Investing.com - Investing.com India
Solas Capital discloses dealings in Mural Oncology shares - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com India
BlackRock reports stake in Mural Oncology - Investing.com Australia
Quarterly Metrics: Quick and Current Ratios for Mural Oncology plc (MURA) - DWinneX
Geode Capital reports 1.02% stake in Mural Oncology By Investing.com - Investing.com South Africa
Largest borrow rate increases among liquid names - TipRanks
Geode Capital reports 1.02% stake in Mural Oncology - Investing.com
Mural Oncology Plc (MURA) 財務データ
Mural Oncology Plc (MURA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Mural Oncology Plc (MURA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Mar 05 '25 |
Sale |
3.45 |
1,469 |
5,068 |
73,564 |
| Keson-Brookes Maiken | See Remarks |
Mar 04 '25 |
Sale |
3.36 |
1,262 |
4,240 |
75,033 |
| Loew Caroline | Chief Executive Officer |
Mar 04 '25 |
Sale |
3.36 |
4,313 |
14,492 |
305,590 |
1.72%
0.85%
大文字化:
|
ボリューム (24 時間):